Remove Bacteria Remove Genome Remove Genomics
article thumbnail

Experts prefer whole genome sequencing as viable option to identify & characterize bacteria as concerns of AMR escalate

AuroBlog - Aurous Healthcare Clinical Trials blog

As antimicrobial resistance (AMR) poses a growing threat to global public health, challenging the effectiveness of antibiotics and other antimicrobial drugs, medical experts suggest whole genome sequencing as a viable option to identify and characterize the bacteria, viruses, fungi or parasites, along with their transmission pattern.

Bacteria 180
article thumbnail

Improving tracking of AMR bacteria in hospitals using new genomic technique

Pharma Times

The spread of multiple bacteria could be tracked simultaneously through sequencing method

Bacteria 117
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The future of genomic medicine: can it fulfil its promises?

pharmaphorum

Here he gives us a deeper look at how genomic medicine is evolving and the barriers that are preventing it from reaching its full potential. I saw this, in particular, with the finishing of the human genome,” says Charlie. “At In reality, finishing the human genome was the first step of what is a long journey.”.

Genomics 119
article thumbnail

Hybrid microbes: Genome transfer between different bacteria strains explored

Scienmag

Bacteria integrate genetic material from other bacterial strains more easily than previously thought, which can lead to improved fitness and accelerated evolution. The team analysed genome transfer between bacteria of different lineages. This is shown in a recent study by biophysicists at the University of Cologne.

article thumbnail

Intestinal bacteria may be an important piece in the jigsaw puzzle of multiple sclerosis

Medical Xpress

Multiple sclerosis patients do not have the same bacteria in their intestines as healthy people. There are also differences in the composition and function of the bacteria in the intestines of multiple sclerosis patients, depending on whether their illness is active, and whether they are in treatment.

Bacteria 104
article thumbnail

Genome sequencing could curb hospital infection outbreaks

Medical Xpress

The spread of antibiotic resistant bacteria in hospitals could be greatly reduced thanks to research by The University of Queensland and Queensland Health.

Genome 97
article thumbnail

Leading innovators in CRISPR nucleases for the pharmaceutical industry

Pharmaceutical Technology

Innovation S-curve for the pharmaceutical industry CRISPR nuclease is a key innovation area in pharmaceutical development CRISPR, which refers to clustered regularly interspaced short palindromic repeats, are bacteriophage-derived DNA sequences that had previously infected the prokaryote and are found in the genomes of bacteria and archaea.

In-Vivo 162